GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$17.14
+0.12%Institutional positioning
13F filings over the trailing two quarters
New 100Increased 24Reduced 10Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Flagship Pioneering, LLC | Unchanged | 62,673,117 | Aug 14, 2026 |
| FLAGSHIP PIONEERING INC. | New Position | 62,673,117 | May 15, 2026 |
| FMR LLC | Increased | 5,221,599 | Aug 13, 2026 |
| FMR LLC | New Position | 4,217,524 | May 15, 2026 |
| Capital World Investors | Increased | 4,215,632 | Aug 12, 2026 |
| CAPITAL WORLD INVESTORS | New Position | 4,004,149 | May 13, 2026 |
| BRAIDWELL LP | New Position | 3,592,999 | May 15, 2026 |
| BRAIDWELL LP | Reduced | 3,283,844 | Aug 14, 2026 |
| JPMORGAN CHASE & CO | New Position | 2,947,259 | May 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 2,156,627 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | New Position | 2,109,633 | May 15, 2026 |
| NORGES BANK | New Position | 2,094,616 | Aug 12, 2026 |
| ARCH Venture Management, LLC | Unchanged | 1,944,426 | Aug 14, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | New Position | 1,944,426 | May 15, 2026 |
| HARBOURVEST PARTNERS LLC | New Position | 1,722,210 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings